CLINICAL_TRIALS
research
· 2012-10-30
Clinical Trial Update: Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy [Phase 2, Phase 3]
Summary
Clinical trial update on injecting botulinum toxin type A into salivary glands to treat drooling in children with cerebral palsy. It encompasses Phase 2 and Pha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital Vall d'Hebron | Conditions: Sialorrhea, Cerebral Palsy | Phase 2, Phase 3 | Status: UNKNOWN